Search

Your search keyword '"Projectafdeling ALS"' showing total 359 results

Search Constraints

Start Over You searched for: Author "Projectafdeling ALS" Remove constraint Author: "Projectafdeling ALS"
359 results on '"Projectafdeling ALS"'

Search Results

151. Excitability of motor and sensory axons in multifocal motor neuropathy

152. Dutch population structure across space, time and GWAS design

153. Current trends in the clinical trial landscape for amyotrophic lateral sclerosis

154. Is it accurate to classify ALS as a neuromuscular disorder?

155. Nerve ultrasound for diagnosing chronic inflammatory neuropathy: a multicenter validation study

156. Clinical outcomes in multifocal motor neuropathy: A combined cross-sectional and follow-up study

157. A placebo-controlled trial to investigate the safety and efficacy of Penicillin G/Hydrocortisone in patients with ALS (PHALS trial)

158. TRICALS: creating a highway toward a cure

159. The Beginning of Genomic Therapies for ALS

160. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion

161. The distinct traits of the UNC13A polymorphism in amyotrophic lateral sclerosis

162. A proposal for new diagnostic criteria for ALS

163. Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis

164. Neuro-imaging in amyotrophic lateral sclerosis: Should we shift towards the periphery?

165. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases

167. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome

168. Blended psychosocial support for partners of patients with ALS and PMA: results of a randomized controlled trial

169. Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis

170. Relative hyperventilation in non-ventilated patients with spinal muscular atrophy

171. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study

172. Connectome-based propagation model in amyotrophic lateral sclerosis

173. Analysis of FUS, PFN2, TDP-43, and PLS3 as potential disease severity modifiers in spinal muscular atrophy

174. Primary lateral sclerosis: consensus diagnostic criteria

175. In pursuit of the normal progressor: the holy grail for ALS clinical trial design?

176. T2 relaxation-time mapping in healthy and diseased skeletal muscle using extended phase graph algorithms

177. Natural history of lung function in spinal muscular atrophy

178. Psychological distress in partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: what's the role of care demands and perceived control?

179. Assessment of motor unit loss in patients with spinal muscular atrophy

180. Associations between illness cognitions and health-related quality of life in the first year after diagnosis of amyotrophic lateral sclerosis

181. Telehealth as part of specialized ALS care: feasibility and user experiences with 'ALS home-monitoring and coaching'

182. The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review

183. In training for a marathon: Runners and running-related injury prevention

184. Drug treatment for spinal muscular atrophy types II and III

185. Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS

186. Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R

187. Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies

188. Multifocal motor neuropathy: controversies and priorities

190. KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia

191. Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure?

192. This title is unavailable for guests, please login to see more information.

193. Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group, randomised, open-label, superiority trial

194. Human immune globulin 10% with recombinant human hyaluronidase in multifocal motor neuropathy

196. Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study

197. Support needs of caregivers of patients with amyotrophic lateral sclerosis: A qualitative study

198. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis

199. Occupation and motor neuron disease: a New Zealand case-control study

200. Two heads are better than one: benefits of joint models for ALS trials

Catalog

Books, media, physical & digital resources